Gossamer Bio, Inc. Quarterly Share-based Payment Arrangement, Expense in USD from Q1 2018 to Q4 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
Gossamer Bio, Inc. quarterly/annual Share-based Payment Arrangement, Expense history and growth rate from Q1 2018 to Q4 2024.
  • Gossamer Bio, Inc. Share-based Payment Arrangement, Expense for the quarter ending December 31, 2024 was $4.97M, a 59.2% decline year-over-year.
  • Gossamer Bio, Inc. Share-based Payment Arrangement, Expense for the twelve months ending December 31, 2024 was $20.6M, a 27.7% decline year-over-year.
  • Gossamer Bio, Inc. annual Share-based Payment Arrangement, Expense for 2024 was $20.6M, a 27.7% decline from 2023.
  • Gossamer Bio, Inc. annual Share-based Payment Arrangement, Expense for 2023 was $28.5M, a 33% decline from 2022.
  • Gossamer Bio, Inc. annual Share-based Payment Arrangement, Expense for 2022 was $42.6M, a 32.9% increase from 2021.
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Quarterly (USD)
Share-based Payment Arrangement, Expense, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q4 2024 $20.6M $4.97M -$7.19M -59.2% Oct 1, 2024 Dec 31, 2024 10-K 2025-03-13
Q3 2024 $27.8M $4.84M -$1.32M -21.4% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-07
Q2 2024 $29.1M $5M -$3.2M -39% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-12
Q1 2024 $32.3M $5.81M +$3.81M +191% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-07
Q4 2023 $28.5M $12.2M +$710K +6.2% Oct 1, 2023 Dec 31, 2023 10-K 2025-03-13
Q3 2023 $27.8M $6.16M -$3.96M -39.1% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-07
Q2 2023 $31.8M $8.2M -$1.8M -18% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-12
Q1 2023 $2M -$8.98M -81.8% May 5, 2023 10-K 2025-03-13
Q1 2023 $33.6M $8.13M -$2.86M -26% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-07
Q4 2022 $42.6M $11.4M +$3.79M +49.5% Oct 1, 2022 Dec 31, 2022 10-K 2025-03-13
Q3 2022 $38.8M $10.1M +$2.54M +33.4% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-09
Q2 2022 $36.2M $10M +$1.95M +24.1% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-08
Q1 2022 $34.3M $11M +$2.28M +26.1% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-09
Q4 2021 $32M $7.66M -$5.02M -39.6% Oct 1, 2021 Dec 31, 2021 10-K 2024-03-05
Q3 2021 $37M $7.59M -$1.34M -15% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-03
Q2 2021 $38.4M $8.05M -$846K -9.51% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-09
Q1 2021 $39.2M $8.71M +$464K +5.63% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-10
Q4 2020 $38.7M $12.7M +$5.82M +84.8% Oct 1, 2020 Dec 31, 2020 10-K 2023-03-17
Q3 2020 $32.9M $8.92M +$3.2M +55.8% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-08
Q2 2020 $29.7M $8.9M +$3.76M +73.2% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-09
Q1 2020 $26M $8.24M +$5.16M +167% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-06
Q4 2019 $20.8M $6.86M -$3.94M -36.5% Oct 1, 2019 Dec 31, 2019 10-K 2022-03-03
Q3 2019 $24.8M $5.73M -$12.4M -68.5% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-10
Q2 2019 $37.2M $5.14M +$3.77M +274% Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-11
Q1 2019 $33.4M $3.09M +$2.48M +411% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-12
Q4 2018 $30.9M $10.8M Oct 1, 2018 Dec 31, 2018 10-K 2021-02-26
Q3 2018 $18.2M Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-12
Q2 2018 $1.37M Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-08
Q1 2018 $605K Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-14
* An asterisk sign (*) next to the value indicates that the value is likely invalid.